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Summary
Over the last few decades, cancer has been regarded as an independent and self sustaining progression. The earliest
hallmarks of cancer comprise of sustaining proliferative signalling, avoiding growth suppressors, resisting cell death,
enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Nonetheless, two
emerging hallmarks are being described: aberrant metabolic pathways and evasion of immune destruction. Changes in
tumour cell metabolism are not restricted to tumour cells alone; the products of the altered metabolism have a direct
impact on the activity of immune cells inside the tumour microenvironment, particularly tumour-associated macrophages (TAMs). The complicated process of cancer growth is orchestrated by metabolic changes dictating the tight
mutual connection between these cells. Here, we discuss approaches to exploit the interaction of cancer cells' abnormal
metabolic activity and TAMs. We also describe ways to exploit it by reprogramming fatty acid metabolism via TAMs.
Keywords: Fatty acid metabolism, Palmitic acid, Oleic acid, Invasion, Metastasis, Tumour-associated macrophages

1. Introduction

T

he tumour microenvironment (TME) is a
complex environment in which cancer cells
develop and are driven by an intimate crosstalk of
intra- and extracellular compartments, which includes inﬂammatory cells, ﬁbroblasts, malignant
cells, and endothelial cells. Furthermore, the scaffold structure surrounding the cells and the soluble
substances secreted by the cells are all mixed in with
cancer cells. Extracellular metabolites are also
involved in these intricate interactions, which are
linked to the development of hypoxia, inadequate
nutritional availability, accumulation of metabolic
products, and unfavourable pH. All of these parameters have a signiﬁcant impact on the deﬁnition
of cancer cell metabolism pathways [1,2]. The cancer-associated metabolites not only provide energy
to cancer cells, but also act as communication signals that are tailored to their high energy demands,
uncontrolled proliferation, and adaptation to

shifting cellular roles and functions [3,4]. In these
conditions, the level of tumour metabolic environment may be exploited or hampered by a plethora
of mechanisms intrinsically associated to cancer
growth, such as colonisation of new metastatic
niches and immunosurveillance evasion.
Aside from these elements, inﬂammatory cells in
the microenvironment surrounding the tumour also
contribute to cancer growth and progression. In
1863, Rudolph Virchow proposed that inﬂammation
contributes to the development of cancer by
implying the presence of inﬁltrating immune cells at
the site of the tumour lesion in the inﬂamed tissue
area [5]. Approximately 50% of the macrophage
population has been detected in solid tumours and
has been shown to perform an important pro-tumoral role [6,7]. Macrophages are heterogeneous
and have a wide range of plasticity and functionality, allowing them to differentiate between separate phenotypes known as M1 (anti-tumoral
phenotype) and M2 (pro-tumoral phenotype)
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depending on microenvironmental stimuli [8,9].
These macrophages are predominantly found inﬁltrated and differentiated within the TME and are
known as “tumour-associated macrophages” or
TAMs at all stages of tumour growth [10]. Cancer
cells' bidirectional metabolic interactions with
TAMs are hypothesised to contribute to carcinogenesis via altered metabolism metabolites.
In order to meet the increased demand for
biosynthesis during high levels of proliferation,
cancer cells within the tumour compartment must
reprogramme their fatty acid metabolism to
conform to metabolic symbiosis. In general, fatty
acids (FAs) are macromolecules that participate in a
variety of cellular activities, such as providing substrates for energy synthesis [11], developing cell
membrane structure [12], and signalling pathway
modiﬁcation [13]. Other studies have demonstrated
that FAs have a substantial effect on the development of immune cells, particularly macrophages, as
well as their activation and functions, with a
considerable effect on the balance of anti- and proinﬂammatory signals in both homeostatic state and
immunological response [14,15].
In this review, we discuss recent ﬁndings
regarding the roles of FAs, speciﬁcally palmitic acid
(PA) and oleic acid (OA), as key players in metabolic
circuits that allow cancer progression in conjunction
with the ability of TAMs to structure the development of tumour microenvironment and address the
metabolic stimuli involved in bidirectional communications between cancer cells and TAMs. We
also present a platform for developing novel concepts for inhibiting cancer progression by targeting
and manipulating FA metabolism in cancer cells.

2. Fatty acid uptake/De novo fatty acid
synthesis in cancer cells and macrophages
Intrinsic and extrinsic signals from cells regulate
metabolic pathways to modify the metabolic machinery that regulates the systhesis of key metabolites to fulﬁl in cellular growth demands. FAs, for
instance, are required by highly proliferating cancer
cells to maintain cell growth [16], disseminate [17],
regulate membrane assembly [18], trigger proliferative signalling [19], and act as bioenergetic needs
[20]. In the context of immunity, changes in metabolic pathways inﬂuence immune effector activities,
most notably the macrophage polarisation and the
inﬂammatory response [21,22].
Nonetheless, Warburg published a crucial work in
the 1920s explaining how neoplastic cells prefer
glycolytic ATP production, followed by lactate generation as the ultimate product, over mitochondrial
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oxidation, regardless of the availability of sufﬁcient
oxygen [23,24]. The Warburg effect is the name
given to this phenomena. In addition, de novo fatty
acid synthesis is a signiﬁcant cancer hallmark. FA
synthesis is a dynamic interaction of metabolic
pathways that is critical for the development of
cellular membranes as well as the production of
crucial synthetic precursors required for cancer cell
growth [25]. The availability of metabolites from
other cell intrinsic metabolic pathways, such as
glycolytic and tricarboxylic acid (TCA) cycle metabolism, has a signiﬁcant impact on the end products
of FA synthesis.
The FA synthesis begins with the conversion of
citrate to acetyl-Coenzyme A (acetyl-CoA), which is
then expanded into malonyl-CoA [26]. The de novo
FA synthesis pathway was catalysed by many
enzymatic pathways including two key enzymes,
acetyl-CoA carboxylase (ACC) and fatty acid synthase (FASN) (Fig. 1). Thereafter, FASN elongates
the nascent FA chain in a nicotinamide adenine
dinucleotide
phosphate
(NADPH)-dependent
manner until saturated fatty acid (SFA) palmitate
(PA) is synthesized. FAs generated by FASN are
integrated into lipid droplets as triglycerides (TAGs)
for energy storage and subsequently catabolized by
FA oxidation (FAO) [27].
Cancer cells secrete FAs in a unique way, activating the de novo or endogenous FA synthesis
pathway with resources from the local microenvironment such as glutamine and glucose [28]. Exogenous food lipids are preferentially utilised to
synthesise new structural lipids in normal human
tissue, but de novo FA-synthesis is frequently
inhibited, and FASN expression remains low. On
the contrary, de novo FA synthesis is optimised and
frequently increased in cancer cells. To maintain
their rapid proliferative rate and provide vital energy for metabolic processes, cellular FA supply is
fully dependent on de novo synthesis.
Alternatively, the carnitine shuttle system transports exogenous fatty acids into the mitochondrion
via specialised transporters [29]. FAO is a multistep
catabolic process that converts exogenous longchain FAs into acetyl-CoA, which is then oxidised
via the TCA cycle and the electron transport chain
(ETC) chain to generate ATP (Fig. 1). CD36, a scavenger transmembrane glycoprotein receptor, is
found in a variety of cell types, including tumour
cells [30], adipocytes [31], macrophages [32], and
certain epithelial cells. It is also involved in tumour
metabolism, promoting metastasis and modulating
FA absorption [33].
CD36, also known as fatty acid translocase (FAT),
FA transport protein family (FATPs), solute carrier
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Fig. 1. The metabolic characteristics of the epithelial-to-mesenchymal transition (EMT) as well as an overview of the metastatic cascade. Several
components of the molecular pathways that drive EMT have a major impact on cell metabolism and vice versa, leading in metabolic rewiring within
the glycolysis, tricarboxylic acid (TCA) cycle, and fatty acid production pathways. Exogenous absorption and de novo lipogenesis are two methods by
which cancer cells obtain fatty acids (FAs). CD36, a specialised transporter, facilitates exogenous FA uptake from the environment. FAs can then be
stored as lipid droplets and integrated into triglycerides for energy storage, as well as used to produce acetyl-coA via FA-oxidation. Cancer cells also
use glucose as a carbon source for de novo lipogenesis in order to synthesise citrate. The enzymatic activity of ATP-citrate lyase (ACLY), fatty acid
synthase (FASN), and acyl-coA carboxylase produce FAs from citrate (ACC). Furthermore, depending on the oxygen tension, EMT-committed cancer
cells may rely on an aerobic glycolytic metabolism or shift toward oxidative phosphorylation (OXPHOS). The suppression of stearoyl-CoA desaturase
1 (SCD1) in cancer cells produces endoplasmic reticulum (ER) stress and apoptosis, demonstrating that decreasing oxygen tension causes changes in
metabolism via fatty acid desaturation. VEGF stands for vascular endothelial growth factor, MMP stands for matrix metalloproteinases, and NLRP3
stands for NLR family pyrin domain containing 3.

protein family 27 (SLC27), and plasma membrane
fatty acid-binding proteins (FABPpm) are discovered to be highly expressed in tumours and are
implicated in the FA de novo synthesis [34]. Exogenous FAs are activated to fatty acyl-CoA before
being shuttled into the mitochondrion for FAO by
the enzyme carnitine palmitoyltransferase I (CPT1)
in the outer mitochondrial membrane. On the matrix side of the inner membrane, Carnitine Palmitoyltransferase II (CPT2) transforms fatty acylcarnitine to acyl-CoA. The ﬁnal phase involves
converting acyl-CoA to acetyl-CoA and its breakdown product via the TCA cycle, which is combined
with oxidative phosphorylation to generate ATP.
Aside from bioenergetic production, FAO-generated acetyl-CoA can be transferred to the cytoplasm
via the TCA cycle and used to regulate cytosolic
NADPH [27].
Despite the plasticity of metabolic circuits, macrophages preferred to have a distinct metabolic
phenotype to meet their functional requirements. In
general, macrophages favour certain metabolic

pathways for energy production, primarily glycolysis and the pentose phosphate pathway (PPP).
Other metabolic pathways such as glycolysis, PPP
and the TCA cycle, can be used as precursors for de
novo FA synthesis in addition to providing energy
[35]. In macrophages, FAs and TAGs are generated
through a sequence of enzyme processes known as
de novo lipogenesis. Acetyl-CoA catalyses the formation of FAs, which are then converted to TAGs or
phospholipids and incorporated into the plasma
membrane or oxidised via the oxidation pathway
[29].
Lipid biosynthesis is necessary for anti-tumoral
M1 macrophages to alter the cellular membrane and
produce pro-inﬂammatory mediators [36]. The
metabolic activities of proinﬂammatory M1 macrophages have been thoroughly studied, and they rely
not only on a high glycolytic metabolism to generate
rapid ATP, but also on fuelling the TCA cycle to
produce acetyl-CoA. (Fig. 1). On the other hand,
ATP-citrate lyase converts glucose-derived citrate
into acetyl-CoA. (ACLY). Infantino et al. found that
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ACLY levels increased rapidly in LPS-activated
macrophages and that ACLY activity was suppressed, resulting in decreased amounts of NO,
ROS, and prostaglandin E2 inﬂammatory mediators
[37].
Besides ACLY, sterol regulatory element binding
proteins (SREBPs) regulate lipogenesis, which is
required for the production of FAs and cholesterol
[38]. In LPS-induced macrophages, Srebp1-a, an
isoform of SREBP, is widely expressed, and its
activated genes encode for inﬂammasome components. A study discovered that mice lacking the
Srebp1-a gene have a poor innate immune response
[39]. FASN, like cancer cells, is a major enzyme in
FA production in M1 macrophages, and it is primarily regulated by SREBPs. Carroll et al. demonstrated that the FASN intermediate metabolite,
acetyl-CoA, contributes to the cellular process of
lipopolysaccharides (LPS) even when they are not
involved in palmitate production [40].
Anti-inﬂammatory M2 macrophages have an
intact TCA cycle and metabolic changes that result
in enhanced FAO and mitochondrial OXPHOS,
both of which are driven by FA absorption [36]. FAs
are taken up by M2 macrophages through lipolysis
of circulating lipoproteins and FAs that are internalised via CD36 and can transcriptionally activate
the nuclear receptors peroxisome proliferator-activated receptor gamma (PPAR) and peroxisome
proliferator-activated receptor gamma coactivator-1
beta (PGC-1b) [41].
FAs are taken up by M2 macrophages via lipolysis
of circulating lipoproteins and FAs that are internalised via CD36 and can transcriptionally activate
the nuclear receptors peroxisome proliferator-activated receptor gamma (PPAR-b) and peroxisome
proliferator-activated receptor gamma coactivator-1
beta (PGC-1 b) [42]. The PPAR activation in M2
macrophages mechanistically regulates the activation of the oxidative programme in these cells
(Fig. 2). As indicated by the transcription of M2
macrophage characteristic genes in response to OA
and IL4 stimulation, PPARs function as FA sensors
and transcriptional activators of the FAO enzyme
[43]. PPAR has recently been linked to the regulation of integrin b3-mediated M2 polarisation, with
integrin b3 decreasing M2 polarisation by inhibiting
PPAR overexpression [44]. Due to FA generation is
required to fuel FAO and FAO plays a critical role in
M2 activation, Huang et al. discovered that TAG
substrate uptake via CD36 and subsequent lipolysis
by lysosomal acid lipase (LAL) is more expressed in
M2 macrophages than in M1 macrophages and is
required for complete macrophage M2 activation
upon IL-4 induction [45]. These data suggested that
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exogenous TAG absorption and lipolysis may
contribute to FAO production during M2 activation.

3. Molecular mechanisms of fatty acid
metabolism in cancer metastasis
Cancer metastasis is a complex process that has
received a great deal of attention. Cancer cells
spread from initial lesions to distal organs via
extravasation from blood vessels, efﬁcient inﬁltration in the bloodstream, colonisation of a new
metastatic niche, tumour angiogenesis formation,
and escape from a lethal immune-cell conﬂict. The
invasion-metastatic cascade occurs as a result of
cancer cells inﬁltrating or partnering with stroma,
escaping immunosurveillance by immunoediting
effector cell functions, evading and modifying the
TME, and evolving drug resistance.
Cancer cells become aggressive and migrate from
the epithelial origin borders into the surrounding
stroma when metastatic progression begins [46].
Therefore, the epithelialmesenchymal transition
(EMT) process has emerged as an important mode
of metastatic potential. EMT can also be deﬁned as a
series of well-coordinated changes in which cells
become immobile and strongly connected to the
adjacent extracellular matrix (ECM), resulting in
changes in FA metabolism [47,48]. Tumour cells
with a mesenchymal phenotype and epithelialmesenchymal phenotypic plasticity are more effective in circulating and priming for secondary site
colonisation and metastatic formation [49].
FASN enzyme is involved in the endogenous
synthesis of PA and its overexpression has been
linked to poor prognosis, recurrence, and aggressiveness in a variety of cancers [50]. According to Li
et al., FASN enhanced EMT in MCF-7-MEK, human
breast cancer cell lines via regulating liver fatty acidbinding protein (L-FABP), VEGF, and VEGFR-2 [51].
Overexpression of FASN protein most likely resulted in an excess of long chain FA production, which
was then transported to the cell membrane by LFABP. This also causes EMT to occur because the
ligand VEGF inﬂuences the position of the membrane protein receptor, VEGFR2, via lipid rafts [52].
A recent comprehensive proteome study using
isobaric tags for relative and absolute quantitation
(iTRAQ)-based spectrometry discovered the FASNinteracting protein network, which is thought to be
important in the regulation of hepatocarcinoma invasion and metastasis [53]. The bioinformatics
technique discovered four proteins (FSCN1, SIPA1,
SPTBN1 or CD59) that interact with FASN and
govern hepatocarcinoma invasion and metastasis,
potentially by regulating EMT and MMPs.
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Fig. 2. Metabolic control of M1 and M2 macrophage mitochondrial components is implicated in immunological activities. Changes in metabolic
pathways such as the TCA cycle, oxidative phosphorylation (OXPHOS), and fatty acid oxidation (FAO) might result in completely different immune
functioning proﬁles. Due to glycolytic ﬂux is higher in M1 macrophages, the TCA cycle experiences two breakdowns resulting in elevated citrate
levels. Citrate drives FA synthesis, which results in the formation of nitric oxide (NO) and prostaglandins. The second break occurs, resulting in higher
succinate levels which stabilises hypoxia-inducible factor 1-alpha (HIF-1) and, as a result, increases interleukin-1 beta (IL-1) production and
inﬂammation. On the other hand, M2 macrophages use a metabolic pathway that is fueled by FAs and OXPHOS, which are critical for M2
macrophage anti-inﬂammatory action. Due to glycolysis is hampered in M2 macrophages due to reduced HIF-1 activity, M2 macrophages redirect
FAs toward re-esteriﬁcation and FA-oxidation. Lipolysis of circulating lipoproteins and FAs, which are internalised via CD36, boosted lipid absorption in M2 macrophages. The stimulation of OXPHOS in M2 macrophages is demonstrated mechanistically by the expression of peroxisome
proliferator-activated receptor gamma (PPAR). NADPH stands for nicotinamide adenine dinucleotide phosphate, acetyl-CoA stands for acetyl-Coenzyme A, fatty acyl-CoA stands for fatty acyl-Coenzyme A, acyl-CoA stands for acyl-Coenzyme A, FASN stands for fatty acid synthase. Triglyceride, triglyceride, triglyceride, triglyceride CPT-1: carnitine palmitoyltransferase-1; CPT-2: carnitine palmitoyltransferase-2; mROS:
mitochondrial reactive oxygen species; CPT-3: carnitine palmitoyltransferase-3; CPT-4: carnitine palmitoyltransferase-4; CPT-5: carnitine
palmitoyltransferase.

Cancer cells that successfully EMT become
circulating cancer cells (CCCs) before spreading and
entering the bloodstream. CCCs' ability to survive
and colonise new niches is determined by their interactions with microenvironmental stimuli. The
hybrid glycolysis/OXPHOS metabolic phenotype
gives numerous beneﬁts to cancer cell metabolic
adaptability. Nonetheless, it was shown that CCCs
may promote distant metastasis by adapting to the
lymph node (LN) microenvironment through the
use of many FAs. Yes-associated protein (YAP) is
speciﬁcally activated in LN-metastatic tumours,
resulting in the overexpression of genes involved in
the FAO signalling pathway for metabolic shift to
FAO [17].
While some ECM remodelling occurs often in the
premetastatic niche, further changes inside the
metastatic niche are required to promote cancer cell
spread. The FA metabolism is an important process
inﬂuenced by hypoxia [54]. Normal cells

predominantly rely on external FA uptake, whereas
cancer cells aggressively reactive de novo FA synthesis, regardless of circulating FA levels [55]. Cells
developing under normoxia create unsaturated fatty
acids (UFAs) from saturated fatty acids (SFAs) such
as PA via oxygen-dependent desaturation. Another
FA-related metabolic enzyme, stearoyl-CoA desaturase, regulates this process (SCD1). Therefore,
hypoxic cancer cells have a deﬁcient desaturation
stage and rely heavily on UFAs produced from the
environment to maintain cellular processes such as
membrane formation and signalling [16,56].
SCD1 is a key lipogenic enzyme in the de novo
synthesis of FA. It regulates tumorigenic events by
converting saturated fatty acids (SFAs) such as palmitic acid (C:16) and stearic acid (C:18) into monounsaturated counterparts such as palmitoleic acid
(16:1n-7) and oleic acid (C18:1n9) (Fig. 1) [57].
Several evidences suggested that SCD1 overexpression and MUFA anomalies were involved in
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the progression of a range of human malignancies,
including prostate, colorectal, and lung cancers
[58e60]. SCD1 activation is responsible for modifying intracellular SFA/MUFA ratios and is linked to
the FA metabolism.
In human mesenchymal stromal cells (hMSC),
SCD1 expression generated by liver X receptors
(LXRs) resulted in a signiﬁcant decrease in PAinduced cell mortality, caspase 3/7 activation, endoplasmic reticulum (ER) stress, and inﬂammation [61].
An epidemiological cohort study previously indicated that the FA desaturation index measured in
blood lipids was associated to lower SCD1 activity
and a lower risk of breast cancer [62]. These epidemiological data revealed why suppressing SCD1
expression inhibits breast cancer cell proliferation
and invasion while also having a strong inhibitory
effect on tumour development and growth. According to the data, both human serum and glucocorticoid-inducible kinase 1 (SGK1) have a similar role in
the FA absorption and survival of NCI-H460 hypoxic
human cancer cells. On the other hand, the addition
of OA dramatically increased the survival of serumdeprived hypoxic NCI-H460 cells, whereas PA was
severely hazardous to the cells [54].
PA has been shown to increase metastatic potential in a CD36-dependent manner. According to
Pascual et al., PA increases the size and frequency of
CD36-dependent lymph node metastasis in oral
squamous cell carcinomas (OSCCs) and increases
the metastatic potential of CD36þ metastasis
without affecting primary tumour growth [30]. The
discovery is consistent with the ﬁndings of Pan et al.,
who discovered that CD36 is involved in the clearance of lipids from the extracellular environment
[63]. They found that phosphorylating AKT in gastric
cancer cells causes glycogen synthase kinase 3 (GSK3)/-catenin degradation and promotes CD36-regulated gastric cancer metastasis. It was also discovered that adding PA to oesophageal squamous
carcinoma (ESCC) improves cell survival and works
as an energy source, showing that CD36 is a vital fuel
for cancer growth. When compared to essential
amino acid treatment, Yoshida et al. found that PA
therapy signiﬁcantly increased cell viability in
TE15 cells expressing CD36 [64]. Surprisingly, CD36blocking antibodies generate a signiﬁcant buildup of
unmetabolized endogenously formed lipids, resulting in impaired metastatic lipotoxicity and cell death
[30]. Their ﬁndings suggest that CD36þ metastasis
starting cells rely on dietary lipids to drive metastasis
in a CD36-dependent manner.
According to Wen et al., the activation of sterol
regulatory element binding transcription factor 1 c
(SREBP-1c) controls the expression of FASN and
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SCD1. SREBP-1c inhibition restored migratory and
invasion abnormalities in AGS and SGC-7901
gastric cancer cells [65,66]. These enzymatic alterations reduced PA synthesis, which inhibited AGS
and SGC-7901 cell motility and invasion in a concentration-dependent manner. OA enhances cervical cancer migration and growth via activating
CD36-dependent activation of Src kinase and
downstream of the ERK1/2 pathway [67]. Otherwise,
the OA triggered the AMP-activated protein kinase
(AMPK) pathway in highly metastatic cancer cells
such as gastric carcinoma, HGC-27, and breast
carcinoma, MDA-MB-231, which showed opposing
responses to low metastatic cancer cells [68]. AMPK
is an important mediator in regulating cellular energy homeostasis and helps in the maintenance of
high ATP levels. When AMPK is activated, ATP
levels are maintained while FA -oxidation is
increased, implying that these high metastatic carcinoma cells may consume OA to support malignancy [69].
Given the prevalence of FAs synthesis pathways
in cancer, the integration of podosomes and invadopodia coordinates the invasive and migratory
capabilities of normal and tumour cells, respectively. As previously discussed, the FA synthesis
pathway may create metabolic cues to facilitate
cancer cell invasion and metastasis via membranemediated mechanisms such as podosomes and
invadopodia. Exogenous palmitate (C16:0) and
oleate (C18:1) can restore cell invadopodia by
inhibiting acetyl-CoA carboxylase 1 (ACC1) activity
[70]. The suppression of ACC1 causes membrane
lipid composition to be disrupted. This is consistent
with the involvement of FA metabolism and invadopodia, which have been related to tumour cell
spreading potential via membraneecytoskeleton
interactions.
The imbalanced ratio of saturated to unsaturated
phospholipids caused by accumulation of free
cholesterol in the ER and exogenous addition of SFA
have previously been shown to induce ER stress and
initiate the unfolded protein response (UPR) [71,72].
Increased SFA accumulation inhibits SCD1 and induces cell death in glioblastoma cancer stem cells
via an overactive ER stress response [73]. According
to Huang et al., the end product of FASN activity,
PA, signiﬁcantly reversed the effect of a-mangostin
ER stress and autophagy induction [74].
The composition and ﬂuidity of the cellular
membrane highlight the structural function and
biological qualities of living cells, which include cell
growth and division, receptor signalling, enzymatic
activity, and celleenvironment interaction [75].
Previous studies have shown that membrane

ﬂuidity is directly related to metastasis and the efﬁciency of newly discovered antimetastasis drugs is
dependent on their capacity to reduce membrane
ﬂuidity. Membrane ﬂuidity is known to be affected
by the ratio of different FA chain lengths in the
membrane bilayer and cellecell contact. Lin et al.
discovered that PA inhibits the formation of hepatocellular carcinoma (HCC) via inhibiting glucose
absorption and energy metabolism [76]. Their proliferation data revealed that PA administration
reduced LM3 cell membrane ﬂuidity and ATP production, speciﬁcally reducing malignant cell proliferation and impairing cell invasiveness. Notably,
the administration of PA to nude mice carrying LM3
cell carcinoma xenografts inhibited tumour growth
and the creation of metastatic nodules.
Meanwhile, an in vivo study found that antimetastasis medication treatment reduced metastatic
nodules, which may be reversed by restoring
ﬂuidity by OA injection. Membrane ﬂuidizer OA
treatment results in loose membrane packing and
increased membrane ﬂuidity [77]. However, antimetastasis drugs may reduce membrane ﬂuidity in a
variety of cell types. These studies demonstrated
that a membrane's lipid composition plays a signiﬁcant role in regulating membrane ﬂuidity,
maintaining cellular activities, cell migration, and
treatment resistance in cancer [78]. Intriguingly,
cancer cells with high levels of lipid saturation and
low membrane ﬂuidity are found to be resistant to
chemotherapeutics due to decreased drug uptake,
highlighting the relationship between membrane
ﬂuidity and membrane permeability and implying a
possible relationship between FA synthesis and
drug resistance.

4. Fatty acid metabolism and metastasis aided
by TAMs
The mechanism of TAMs in conjunction with their
FA metabolism changes is also important in the successful metastasis of cancer cells. Macrophages
within the TME contribute to a growth-suppressive
state, although these cells may be reprogrammed by
the tumour to exhibit pro-tumorigenic behaviours
later on. On the other hand, TAMs promote phenotypic plasticity in the main tumour site, including
invasion, vascularization, intravasation, extravasation, premetastatic niches, and CCC survival.
Metastatic tumour cells reconstructed their basal
membrane by abandoning cellecell junctions in
order to cling to the surrounding tissue structure
loosely. A great number of studies have found that
bidirectional metabolic communication between
tumour cells and TAMs plays an important role in
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the regulation of the EMT process. Biologically,
numerous soluble molecules implicated in the EMT
process including as IL-1, IL-8, tumour necrosis
factor (TNF), and transforming growth factor-b
(TGF-b), are secreted by macrophages via activation
of acyl-CoA synthetase, which catalyses the thioesteriﬁcation of FAs [79]. As a result of chemokines
and bidirectional interactions, the tumour niche
creates an immunosuppressive environment by
attracting other cells. The inhibitory programmed
death-1 receptor (PD-1) mediate immunological
checkpoint in T cells will be activated by their ligands, PD-L1 and PDL2, which are produced by
TAMs. An in vivo study by Lau et al. showed that the
PD-1 ligand pathway modulates anti-tumour immunity with TAM-derived PD-L1 contributing to
immunosuppressive responses [80].
CCC dissemination is particularly facilitated by
close interaction with macrophages. Recent studies
suggest that inﬁltrating CD163þ TAMs (M2
phenotype) trigger EMT to increase colorectal cancer migration, invasion, and metastasis through
modulating the JAK2/STAT3/miR-506-3p/FoxQ1
axis, which leads to the production of CCL2 for
macrophage recruitment [81]. TAM-assisted metastasis is facilitated by TAM proteolytic enzymes such
as MMPs, cathepsins, and serine proteases, which
are critical for ECM breakdown and cell-ECM interactions [82e84].
According to Robblee et al., IRE1 is required for
PA therapy to activate the NLRP3 inﬂammasome
[85]. ER stress and NLRP3 inﬂammasome activation
are important in the TLRmediated signalling
cascade, allowing macrophages to secrete proinﬂammatory cytokines, including IL-1 (Fig. 2) [86].
This will stimulate FAO in inﬂammatory macrophages, which will later create an anti-inﬂammatory
impact. It is hypothesised that increased FAO favours M2 macrophages over M1 phenotypes.
Several investigations have found that some M2
macrophages rely on FAO for proinﬂammatory and
pro-migratory effects via FAO-associated ROS
generation and an NLRP3-dependent mechanism,
which could stimulate IL-1 transcription via hypoxia-inducible factor 1-alpha (HIF-1) upregulation
[87].
In contrast to PA, most studies have reported that
OA directly modulates PA-induced metabolism, ER
stress, and inﬂammatory signalling suppression.
OA reduces inﬂammation by decreasing PAsecreted IL-1 and inhibiting the NLRP3 inﬂammasome [88]. Similarly, oleatepalmitate TAGs have
been shown to reduce SFA-induced ER stress and
different proinﬂammatory palmitate metabolites
[89]. OA inhibits intracellular crystallisation, NLRP3
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inﬂammasome activation, and SFAs-triggered IL-1,
such as PA and stearic acid [90].
Notably, the participation of macrophages in
cancer is complicated by their heterogeneity and
phenotype. Lipid droplets contribute to macrophage
polarisation or phenotype, respectively, and oleate
alone is sufﬁcient to induce TAMs at phenotypic
and functional levels, as well as induced substantial
lipid droplet production in human CD14þ monocytes [91]. Wu et al. revealed that, in addition to
cytokine signalling, increasing lipid metabolism,
particularly oleate, is sufﬁcient to convert
CD206þMHCIIlow myeloid cells into M2-like protumoral macrophages. The expression of M2
markers such as Retnal, Arg1, Chile3l3, and CD206
on both mRNA and protein levels was seen in these
oleate-polarized CD206þMHCIIlow myeloid cells.
Aside from these ﬁndings, TAMs discovered in a
mouse mammary cancer were reported to have
signiﬁcant levels of epidermal fatty acid binding
protein (E-FABP), an intracellular lipid chaperone
that increases antitumor action [92]. Thus, it is
inferred that E-FABP is mostly expressed in the M1like macrophage population, and that these E-FABP
expressing macrophages have a higher IFN-b
response via lipid droplet accumulation in response
to unsaturated FAs and tumours. This mechanism
promotes the recruitment of tumoricidal effector
cells, which boosts anti-cancer activity in the TME
[93]. These ﬁndings suggested that macrophages
could use tumour-derived lipids to boost antitumour action in response to unsaturated FAs like
OA by upregulating E-FABP.
Nitric oxide (NO) is an important modulator of
macrophage function, and its expression is linked to
macrophage cytotoxicity against transformed cells
[94]. Abnormal cells within the TME including
macrophages, neutrophils, endothelial cells, ﬁbroblasts, and in some cases, tumours, may produce
NO. Despite its well-established anti-tumorigenic
qualities, NO has been shown to have a dual function, whereby NO expression stimulates tumour
development in some circumstances in a concentration-dependent manner. The potential of NO to
modulate metastatic cell functions such as cell death,
adhesion, motility, secretion, invasion, and angiogenesis explains this apparent discrepancy [95].
For instance, macrophage killing mechanisms
regulated by high NO production to cause apoptosis
of established tumour cells and cell cycle arrest. On
the other hand, low NO concentrations protect cells
from death [96]. Therefore, a high level of NO has
been linked to the activation of an apoptotic
response in tumour formation, and macrophages
may use it as a weapon in their arsenal to penetrate
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and limit the growth of cancer cells. Monmai et al.
found that PA was the most abundant SFA isolated
from the tunic of Halocynthia aurantium, that it
increased the levels of pro-inﬂammatory cytokines
and immunological signalling for immune
enhancement, and that it inhibited NO generation
for anti-inﬂammation in macrophages [97]. According to Monmai et al. and Kim et al., OA strongly
repressed a dose-dependent generation of TNF-,
suppressed iNOS expression, and consequently
decreased NO production in cultured cells.
Furthermore, these hampered COX-2 induction,
which was inconsistent with a full reduction of NO
in culture medium. This suggests that OA inhibits
NF-B binding activity in PC12 cells by preventing
IB- breakdown [98]. Rudnicki et al. provided the ﬁrst
evidence that nitro-fatty acids (NO2-FAs), which
include nitro-oleic acid-induced endothelial cell
migration and sprout formation, stimulated angiogenesis in vivo in a NO-dependent way [99].

5. Conclusions
The modiﬁcation of critical fatty acids in cancer
metabolism has a signiﬁcant impact on cancer invasion and metastasis. FA metabolism is a network
of pathways with plasticity and bidirectional metabolic communication that has been ﬁne-tuned to
satisfy the metabolic needs of cancer cells. Metabolic intermediates by cancer cells can be exploited
as an energy source to fuel their rapid progression,
prevent membrane formation, and modify phenotypic to prime metastatic potential, ﬁnally leading to
aggressive malignant progression. In macrophages,
the differences in FAs metabolism between M1 and
M2 macrophages have merged as an exciting topic,
and metabolic alterations of each type of macrophage correspond closely to their cell function and
phenotype, as well as their implications in pathophysiological lipid-related disease like cancer.
Another topic to explore is identifying metabolic
intermediates implicated in FA metabolism in both
cancer cells and macrophages, which leads to
altered cell expansion and tumour formation. We
would be able to identify and expand the repertory
of actionable metabolic regimes, as well as more
precisely target metabolic communications, as we
continue to investigate metabolic communications,
particularly in the metastatic niche.
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